Cargando…
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Background: Anthracycline (ANT) is often used for breast cancer treatment but its clinical use is limited by cardiotoxicity (CTX). CECCY trial demonstrated that the β-blocker carvedilol (CVD) could attenuate myocardial injury secondary to ANT. Mieloperoxydase (MPO) is a biomarker of oxidative stress...
Autores principales: | Wanderley Jr., Mauro Rogério de Barros, Ávila, Mônica Samuel, Fernandes-Silva, Miguel Morita, Cruz, Fátima das Dores, Brandão, Sara Michelly Gonçalves, Rigaud, Vagner Oliveira Carvalho, Hajjar, Ludhmila Abrahão, Filho, Roberto Kalil, Cunha-Neto, Edécio, Bocchi, Edimar Alcides, Ayub-Ferreira, Silvia Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789241/ https://www.ncbi.nlm.nih.gov/pubmed/35087624 http://dx.doi.org/10.18632/oncotarget.28182 |
Ejemplares similares
-
Long-term Results of a Cardiology Postgraduate
Program
por: Bocchi, Edimar Alcides, et al.
Publicado: (2017) -
Comment on “MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction”
por: Oliveira-Carvalho, Vagner, et al.
Publicado: (2016) -
What is the Role of Two-Dimensional Speckle Tracking Echocardiography
in the Diagnosis and Management of Anthracycline-Induced
Cardiotoxicity?
por: Costa, Isabela Bispo Santos da Silva, et al.
Publicado: (2018) -
Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019) -
A review of cost-effectiveness analysis: From theory to clinical practice
por: Michelly Gonçalves Brandão, Sara, et al.
Publicado: (2023)